These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 17623520)
1. Paraoxonase and arylesterase activities in fibromyalgia. Altindag O; Gur A; Calgan N; Soran N; Celik H; Selek S Redox Rep; 2007; 12(3):134-8. PubMed ID: 17623520 [TBL] [Abstract][Full Text] [Related]
2. Paraoxonase and arylesterase activities in coronary artery disease. Gur M; Aslan M; Yildiz A; Demirbag R; Yilmaz R; Selek S; Erel O; Ozdogru I Eur J Clin Invest; 2006 Nov; 36(11):779-87. PubMed ID: 17032345 [TBL] [Abstract][Full Text] [Related]
3. Assessment of paraoxonase activities in patients with knee osteoarthritis. Soran N; Altindag O; Cakir H; Celik H; Demirkol A; Aksoy N Redox Rep; 2008; 13(5):194-8. PubMed ID: 18796237 [TBL] [Abstract][Full Text] [Related]
4. Paraoxonase and arylesterase activities in untreated dipper and non-dipper hypertensive patients. Yildiz A; Gur M; Demirbag R; Yilmaz R; Akyol S; Aslan M; Erel O Clin Biochem; 2008 Jul; 41(10-11):779-84. PubMed ID: 18355454 [TBL] [Abstract][Full Text] [Related]
5. Serum paraoxonase activity and oxidative stress in patients with adult nephrotic syndrome. Soyoral YU; Aslan M; Emre H; Begenik H; Erdur FM; Turkel A; Selek S; Erkoc R Atherosclerosis; 2011 Sep; 218(1):243-6. PubMed ID: 21723555 [TBL] [Abstract][Full Text] [Related]
6. Serum paraoxonase and arylesterase activities in patients with epithelial ovarian cancer. Camuzcuoglu H; Arioz DT; Toy H; Kurt S; Celik H; Erel O Gynecol Oncol; 2009 Mar; 112(3):481-5. PubMed ID: 19101714 [TBL] [Abstract][Full Text] [Related]
7. Assessment of paraoxonase and arylesterase activities in patients with iron deficiency anemia. Aslan M; Kosecik M; Horoz M; Selek S; Celik H; Erel O Atherosclerosis; 2007 Apr; 191(2):397-402. PubMed ID: 16684543 [TBL] [Abstract][Full Text] [Related]
8. Oxidative status and serum PON1 activity in beta-thalassemia minor. Selek S; Aslan M; Horoz M; Gur M; Erel O Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173 [TBL] [Abstract][Full Text] [Related]
9. Association of paraoxonase activity and atherosclerosis in patients with chronic hepatitis B. Karsen H; Binici I; Sunnetcioglu M; Baran AI; Ceylan MR; Selek S; Celik H Afr Health Sci; 2012 Jun; 12(2):114-8. PubMed ID: 23056015 [TBL] [Abstract][Full Text] [Related]
10. Serum paraoxonase-1 activity in Helicobacter pylori infected subjects. Aslan M; Nazligul Y; Horoz M; Bolukbas C; Bolukbas FF; Gur M; Celik H; Erel O Atherosclerosis; 2008 Jan; 196(1):270-274. PubMed ID: 17125774 [TBL] [Abstract][Full Text] [Related]
11. Paraoxonase and arylesterase activities in patients with cardiac syndrome X, and their relationship with oxidative stress markers. Gur M; Yildiz A; Demirbag R; Yilmaz R; Aslan M; Ozdogru I; Erel O Coron Artery Dis; 2007 Mar; 18(2):89-95. PubMed ID: 17301599 [TBL] [Abstract][Full Text] [Related]
12. Decreased paraoxonase and arylesterase activities in the pathogenesis of future atherosclerotic heart disease in women with gestational diabetes mellitus. Camuzcuoglu H; Toy H; Cakir H; Celik H; Erel O J Womens Health (Larchmt); 2009 Sep; 18(9):1435-9. PubMed ID: 19698032 [TBL] [Abstract][Full Text] [Related]
13. Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with chronic adenotonsillitis. Koc S; Aksoy N; Bilinc H; Duygu F; Uysal IÖ; Ekinci A Int J Pediatr Otorhinolaryngol; 2011 Nov; 75(11):1364-7. PubMed ID: 21893350 [TBL] [Abstract][Full Text] [Related]
14. Serum paraoxonase and arylesterase activity and oxidative status in patients with multiple sclerosis. Kirbas A; Kirbas S; Anlar O; Efe H; Yilmaz A J Clin Neurosci; 2013 Aug; 20(8):1106-9. PubMed ID: 23669169 [TBL] [Abstract][Full Text] [Related]
15. PON1 activity and total oxidant status in patients with active pulmonary tuberculosis. Selek S; Cosar N; Kocyigit A; Erel O; Aksoy N; Gencer M; Gunak F; Aslan M Clin Biochem; 2008 Feb; 41(3):140-4. PubMed ID: 18154731 [TBL] [Abstract][Full Text] [Related]
16. Paraoxonase and arylesterase activities in patients with papillary thyroid cancer. Korkmaz H; Tabur S; Özkaya M; Aksoy N; Yildiz H; Akarsu E Scand J Clin Lab Invest; 2015 May; 75(3):259-64. PubMed ID: 25723374 [TBL] [Abstract][Full Text] [Related]
17. An evaluation of serum paraoxonase together with arylesterase activities and oxidative stress in children with intractable epilepsy: a cross-sectional study. Calik M; Oguz E; Sarikaya S; Kocaturk O; Koca B; Gungor HE; Aksoy N; Yoldas TK; Iscan A Epilepsy Res; 2014 Nov; 108(9):1591-6. PubMed ID: 25218892 [TBL] [Abstract][Full Text] [Related]
18. Paraoxonase and arylesterase activity with oxidative status in children with thalassemia major. Cakmak A; Soker M; Koc A; Erel O J Pediatr Hematol Oncol; 2009 Aug; 31(8):583-7. PubMed ID: 19636263 [TBL] [Abstract][Full Text] [Related]
19. Serum paraoxonase, arylesterase activity and oxidative status in patients with obstructive sleep apnea syndrome (OSAS). Baysal E; Taysi S; Aksoy N; Uyar M; Celenk F; Karatas ZA; Tarakcioglu M; Bilinç H; Mumbuç S; Kanlikama M Eur Rev Med Pharmacol Sci; 2012 Jun; 16(6):770-4. PubMed ID: 22913209 [TBL] [Abstract][Full Text] [Related]
20. Assessment of serum paraoxonase and arylesterase activity in patients with endometrial cancer. Arioz DT; Camuzcuoglu H; Toy H; Kurt S; Celik H; Erel O Eur J Gynaecol Oncol; 2009; 30(6):679-82. PubMed ID: 20099504 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]